Mediclinic Southern Africa is a private hospital group operating in South Africa and Namibia focused on providing acute care, specialist-orientated, multi-disciplinary hospital services and related service offerings. We place science at the heart of our care process by striving to provide evidence-based care of the highest standard.
The group currently operates 48 hospitals, 11 day clinics and 8 sub-acute and specialised hospitals throughout South Africa as well as 3 private hospitals in Namibia, with more than 8780 beds in total. Included in these numbers are day clinics and sub-acute and specialised hospitals operated by Intercare, in which Mediclinic Southern Africa holds a majority stake.
Mediclinic Southern Africa is a wholly owned subsidiary of the international private healthcare group Mediclinic International PLC, listed on the LSE (London Stock Exchange) with a secondary listing on the JSE (Johannesburg Stock Exchange) and the NSX (Namibian Stock Exchange).
Mediclinic International currently has three operating divisions - Mediclinic Southern Africa which operates throughout South Africa and Namibia; Hirslanden operates in Switzerland and Mediclinic Middle East which operates in the United Arab Emirates.
The group also holds a minority interest of 29.9% in Spire Healthcare Group PLC, a leading private hospital group in the United Kingdom, which is also listed on the LSE.
The Mediclinic Group is committed to being a good corporate citizen. This commitment is reflected in our business strategy to ensure we conduct business fairly and ethically.